Theratechnologies Inc. | Income Statement
Fiscal year is December-November. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
7,553.00
6,732.00
30,055.00
37,072.00
42,864.00
58,553
Cost of Goods Sold (COGS) incl. D&A
3,798.00
3,597.00
5,941.00
8,766.00
12,258.00
19,510
Gross Income
3,755.00
3,135.00
24,114.00
28,306.00
30,606.00
39,043
SG&A Expense
11,490.00
16,031.00
20,540.00
25,007.00
41,704.00
43,578
EBIT
7,735.00
12,896.00
3,574.00
3,299.00
11,098.00
4,535
Unusual Expense
3,077.00
4,099.00
402.00
1,022.00
6,797.00
372
Non Operating Income/Expense
33.00
731.00
55.00
10.00
520.00
218
Interest Expense
-
1,207.00
2,503.00
1,981.00
1,413.00
3,341
Pretax Income
4,170.00
10,537.00
1,569.00
410.00
18,450.00
7,675
Income Tax
115.00
4.00
2.00
-
-
1,662
Consolidated Net Income
4,055.00
10,541.00
1,571.00
410.00
18,450.00
6,013
Net Income
4,055.00
10,541.00
1,571.00
410.00
18,450.00
6,013
Net Income After Extraordinaries
4,055.00
10,541.00
1,571.00
410.00
18,450.00
6,013
Net Income Available to Common
4,055.00
10,541.00
1,571.00
410.00
18,450.00
6,013
EPS (Basic)
0.07
0.17
0.03
0.01
0.25
0.08
Basic Shares Outstanding
61,010.60
61,010.60
62,487.00
65,812.60
73,468.90
75,942.40
EPS (Diluted)
0.07
0.17
0.02
0.01
0.25
0.08
Diluted Shares Outstanding
61,010.60
61,010.60
63,171.80
66,595.80
73,468.90
75,942.40
EBITDA
7,631.00
11,754.00
5,491.00
5,407.00
9,106.00
972
Non-Operating Interest Income
455.00
198.00
41.00
104.00
338.00
791
About Theratechnologies
View Profile
